Asuncion J.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 87 partner sites.
Specializations
Early Breast Cancer Treatment
This investigator specializes in the treatment of hormone receptor-positive (HR+) and HER2-negative early breast cancer, with particular focus on developing personalized therapeutic approaches.
- Endocrine Therapy Optimization
- Adjuvant Treatment Strategies
- Dynamic Marker Assessment
The research encompasses evaluation of combination treatments for high-risk breast cancer patients.
HER2-Positive Breast Cancer
The investigator focuses on advancing treatment options for high-risk HER2-positive breast cancer, particularly in cases with residual disease after initial therapy.
- Post-Neoadjuvant Treatment
- Targeted Antibody Therapies
- Disease-Free Survival Enhancement
Areas of interest include innovative therapeutic approaches for resistant disease states.
Advanced Breast Cancer Management
Research interests include treatment of estrogen receptor-positive advanced breast cancer with specific focus on ESR1-mutated disease and resistance mechanisms.
- Endocrine Therapy Resistance
- Novel Therapeutic Combinations
- Targeted Treatment Approaches
The work extends to developing strategies for patients who have progressed on previous therapeutic regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.